Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 10-Jul-23 5:01 PM View:  | Adaptimmune Therapeutics plc (ADAP) | 10-Jul-23 | Sale | 47,702 | $0.91 | $43,447.00 | (39%) 122.76K to 75.06K | |
| 01-Jun-23 4:59 PM View: | Adaptimmune Therapeutics plc (ADAP) | 01-Jun-23 | Grant | 401,293 | -- | -- | 100% 0 to 401.29K | |
| 01-Jun-23 4:59 PM View: | Adaptimmune Therapeutics plc (ADAP) | 01-Jun-23 | Grant | 209,931 | -- | -- | 52% 401.29K to 611.22K | |
| 01-Jun-23 4:22 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 01-Jun-23 | Disposition | 265,459 | -- | -- | (66%) 404.33K to 138.87K | |
| 01-Jun-23 4:22 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 01-Jun-23 | Disposition | 138,871 | -- | -- | (100%) 138.87K to 0 | |
| 13-Dec-22 8:19 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 13-Dec-22 | Sale (Planned) | 11,000 | $1.06 | $11,682.00 | (2%) 586.14K to 575.14K | |
| 13-Dec-22 8:19 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 12-Dec-22 | Sale (Planned) | 10,613 | $1.10 | $11,674.30 | (2%) 596.75K to 586.14K | |
| 13-Dec-22 8:19 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 09-Dec-22 | Sale (Planned) | 10,325 | $1.13 | $11,677.60 | (2%) 607.08K to 596.75K | |
| 09-Dec-22 4:44 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 08-Dec-22 | Sale (Planned) | 9,314 | $1.25 | $11,679.80 | (1%) 634.82K to 625.5K | |
| 09-Dec-22 4:44 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 07-Dec-22 | Sale (Planned) | 9,111 | $1.28 | $11,680.30 | (1%) 643.93K to 634.82K | |
| 07-Dec-22 7:56 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 06-Dec-22 | Sale (Planned) | 14,886 | $1.35 | $20,081.20 | (2%) 682.23K to 667.34K | |
| 07-Dec-22 7:56 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 05-Dec-22 | Sale (Planned) | 8,530 | $1.37 | $11,703.20 | (1%) 690.76K to 682.23K | |
| 05-Dec-22 7:49 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 02-Dec-22 | Planned Option Sale | 8,408 | $1.39 | $11,687.10 | (2%) 486.52K to 478.11K | |
| 05-Dec-22 7:49 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 01-Dec-22 | Option Exercise | 221,058 | -- | -- | 83% 265.46K to 486.52K | |
| 26-Aug-22 4:30 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 05-Jul-22 | Gift | 265,459 | -- | -- | 55% 482.72K to 748.17K | |
| 26-Aug-22 4:30 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 05-Jul-22 | Gift | 84,527 | -- | -- | (11%) 748.17K to 663.65K | |
| 26-Aug-22 4:30 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 05-Jul-22 | Gift | 180,932 | -- | -- | (27%) 663.65K to 482.72K | |
| 18-Mar-22 4:24 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 28-Feb-22 | Grant | 1,425 | $2.30 | $3,277.50 | < 1% 264.03K to 265.46K | |
| 10-Dec-21 4:32 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 09-Dec-21 | Option Exercise | 175,000 | $0.74 | $129,500.00 | 197% 89.03K to 264.03K | |
| 10-Dec-21 4:32 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 31-Aug-21 | Grant | 422 | $14.26 | $6,017.72 | < 1% 88.61K to 89.03K | |
| 08-Mar-21 8:16 AM View: | Tcr2 Therapeutics Inc. (TCRR) | 28-Feb-21 | Grant | 686 | $16.12 | $11,061.40 | < 1% 87.93K to 88.61K | |
| 08-Mar-21 8:16 AM View: | Tcr2 Therapeutics Inc. (TCRR) | 31-Aug-20 | Grant | 1,132 | $10.10 | $11,430.90 | 1% 86.79K to 87.93K | |
| 27-Mar-20 4:15 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 28-Feb-20 | Grant | 1,287 | $10.10 | $12,998.70 | 2% 85.51K to 86.79K | |
| 05-Feb-20 5:56 PM View: | Black Diamond Therapeutics,... (BDTX) | 03-Feb-20 | Conversion | 51,825 | -- | -- | 100% 0 to 51.83K | |
| 27-Mar-20 4:15 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 30-Aug-19 | Grant | 980 | $12.75 | $12,495.00 | 1% 84.53K to 85.51K |